Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01964339 · ClinicalTrials.gov registry record

Obesity Hypoventilation Syndrome Prevalence Study

A clinical trial, sponsored by Philips Respironics.

Terminated
Registry status
44
Enrollment target

NCT01964339: Clinical Trial study, sponsored by Philips Respironics.

NCT01964339 is a clinical trial that was terminated before completion, run by Philips Respironics. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01964339 was terminated before completion, sponsored by Philips Respironics.

TERMINATED
Registry status
44 participants
Enrollment target

Study Summary

This is an observational study to characterize the prevalence of Obesity Hypoventilation Syndrome in patients referred to the sleep lab.

Primary Outcome

The study involves a venipuncture and data collection at the time of sleep study. Data collection will be correlated to blood draw results.

Interventions

  • OTHER BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.
  • OTHER BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2013-10-09
Est. Completion 2014-05-21
Philips Respironics

35 total trials

Why NCT01964339 stopped before completion

NCT01964339 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study. is the first listed.

NCT01964339 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01964339 about?

NCT01964339 is a clinical study titled "Obesity Hypoventilation Syndrome Prevalence Study". This is an observational study to characterize the prevalence of Obesity Hypoventilation Syndrome in patients referred to the sleep lab.

What is the current status of trial NCT01964339?

This trial is currently terminated. The enrollment target is 44 participants. The study started on 2013-10-09. Estimated completion is 2014-05-21.

What interventions are being tested in trial NCT01964339?

The interventions under investigation include: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study. (OTHER), BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study. (OTHER).

Who is sponsoring clinical trial NCT01964339?

This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.

Learn More About Clinical Trials

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01964339, the US trial registry maintained by the National Library of Medicine. NCT01964339 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.